Keyphrases
Esophageal Squamous Cell Carcinoma
100%
Esophageal Cancer
61%
Resection
44%
MicroRNA
41%
Multidisciplinary Treatment
38%
Cancer Stem Cell Properties
35%
Paratracheal Air Cyst
35%
PTAC
35%
Neoadjuvant Therapy
35%
Borderline Resectable Pancreatic Cancer
35%
Video-assisted
35%
CD44v9
35%
Endoscopic Thyroidectomy
35%
Primary Hepatic Neuroendocrine Tumor
35%
Liver
35%
Gastric Tube Cancer
35%
Partial Gastrectomy
35%
Cluster of Differentiation 44 (CD44)
35%
Gallbladder Cancer
35%
MicroRNA-574-3p
35%
Gastric Tube
35%
Bronchogenic Cyst
35%
Surgery Treatment
35%
Isoform Switching
35%
Indocyanine Green Fluorescence
35%
P75 Neurotrophin Receptor (p75NTR)
35%
Neck Surgery
35%
Blood Flow Evaluation
35%
Thoracoscopic Esophagectomy
35%
Postoperative Outcomes
35%
Tumor
30%
Overall Survival
25%
MiR-574-3p
25%
Tumor Suppressor
23%
Cystic Lesion
21%
Older Women
20%
Left Lateral Sectionectomy
17%
Ki-67 Index
17%
Dietary Intake
17%
Hypervascular Tumor
17%
Synaptophysin
17%
Cystic Change
17%
One-stage Breast Reconstruction
17%
Older Breast Cancer
17%
Perforator Flap Surgery
17%
Postoperative Day
17%
Abdominal Tumor
17%
WHO Classification
17%
MiR-877-3p
17%
Tumor Cells
17%
Medicine and Dentistry
Esophagectomy
88%
Esophageal Squamous Cell Carcinoma
71%
Neoplasm
69%
Surgery
65%
Esophageal Cancer
47%
Indocyanine Green
35%
Partial Gastrectomy
35%
Blood Flow
35%
Neoadjuvant Therapy
35%
Malignant Neoplasm
35%
Pancreas Cancer
35%
Neuroendocrine Carcinoma
35%
Cancer Stem Cell
35%
Bronchogenic Cyst
35%
microRNA
35%
Neurotrophin Receptor P75
35%
Thyroidectomy
35%
Neck Surgery
35%
Overall Survival
22%
Recurrent Disease
21%
Anastomosis Leakage
21%
Local Excision
17%
Flap (Surgery)
17%
Breast Cancer
17%
Spin Echo
17%
Tumor Cell
17%
Abdominal Tumor
17%
Duodenum Tumor
17%
Breast Reconstruction
17%
Deep Inferior Epigastric Perforator Flap
17%
Dietary Intake
17%
Liver Tumor
17%
Synaptophysin
17%
Necrosis
17%
Pancreaticoduodenectomy
17%
Paracetamol
17%
Trachea
14%
Elderly Patient
14%
Surgical Anastomosis
12%
Vascularity
11%
Gastroepiploic Artery
11%
Surgical Margin
11%
Long Term Survival
11%
Retroperitoneal Lymph Node Dissection
11%
Pylorus Stenosis
11%
Roux-en-Y
11%
Gastric Artery
11%
Group Therapy
11%
Comorbidity
11%
Bleeding
11%